Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 14/20 | 0.87 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.70 |
| ▸ | RXRA | P19793 | 1/20 | 0.65 |
| ▸ | RXRB | P28702 | 1/20 | 0.65 |
| ▸ | RXRG | P48443 | 1/20 | 0.65 |
| ▸ | FFAR4 | Q5NUL3 | 4/20 | 0.62 |
| ▸ | MMP12 | P39900 | 1/20 | 0.62 |
| ▸ | CA1 | P00915 | 1/20 | 0.59 |
| ▸ | CA2 | P00918 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14066660 | 1.00 | FFAR1 (0.87) | FFAR1KEAP1RXRARXRBRXRG | |
| SCHEMBL8618654 | 0.93 | FFAR1 (1.00) | FFAR1KEAP1RXRARXRBRXRG | |
| SCHEMBL1211561 | 0.93 | FFAR1 (1.00) | FFAR1KEAP1RXRARXRBRXRG | |
| SCHEMBL69746 | 0.92 | FFAR1 (0.81) | FFAR1KEAP1FFAR4CA1CA2 | |
| Hydrochloric Acid SCHEMBL5753893 | 0.91 | FFAR1 (0.96) | FFAR1KEAP1RXRARXRBRXRG | |
| SCHEMBL3293457 | 0.91 | FFAR1 (0.74) | FFAR1KEAP1RXRARXRBRXRG | |
| SCHEMBL7630944 | 0.91 | FFAR1 (0.96) | FFAR1KEAP1RXRARXRBRXRG | |
| Hydrochloric Acid SCHEMBL25264643 | 0.90 | FFAR1 (0.77) | FFAR1KEAP1FFAR4CA1CA2 | |
| SCHEMBL8339608 | 0.89 | FFAR1 (0.71) | FFAR1KEAP1RXRARXRBRXRG | |
| SCHEMBL23512465 | 0.89 | FFAR1 (0.71) | FFAR1KEAP1RXRARXRBRXRG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7816385-B2 | Dimeric dicarboxylic acid derivatives, their preparation and use | HIGH POINT PHARMACEUTICALS, LLC (US) | 2010-10-19 | — | — | US | disclosed |
| US-20040259950-A1 | Novel compounds, their preparation and use | HIGH POINT PHARMACEUTICALS, LLC | 2004-12-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040259950-A1 | Novel compounds, their preparation and use | PPARG, PPARA, PPARD | FFAR1 33/4885KEAP1 2436/4885RXRA 19/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.